The Global Trial Accelerators™ podcast (formerly known as LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
In this episode, we welcome Steven Collens, CEO of MATTER, one of the world’s leading healthcare incubators and innovation hubs. Under Steven’s leadership, MATTER has supported more than 1,000 healthcare startups, helping innovators move faster, collaborate more effectively, and significantly impro…
This episode features Steven Collens , CEO of MATTER , a premier healthcare incubator and innovation hub that has supported over 1,000 healthcare startups. MATTER helps entrepreneurs and organizations innovate faster and more...
In this episode, we welcome Pablo Yarza, a bioinformatics specialist with more than 15 years of experience developing advanced databases for academic and industrial use. Pablo shares his professional journey, the challenges of data curation in R&D environments, and how data quality issues can lead…
In this episode, we sit down with Pablo Yarza , a bioinformatics expert with over 15 years of experience developing advanced databases for both academic and industrial applications. Throughout his career, Pablo has gained dee...
In this episode, we welcome Scott Stout, a leader focused on transforming access to clinical trials through innovative provider engagement models. Through HCP Recruitment, Scott and the team at MedVector are redefining how clinical trial sites connect with patients by unlocking access to larger, mo…
This episode features Scott Stout , who is helping reshape clinical trial recruitment through MedVector’s innovative HCP Recruitment model. By engaging community physicians in a new way, MedVector enables access to larger and...
In today's fast-paced business environment, building a high-performing team is paramount to achieving sustainable success. Nowhere is this truer than in the demanding world of private equity, where the stakes are high and the pressure to deliver exc…
Welcome to the blog! In this post, we'll be exploring the extraordinary career of Dr. Joseph Palumbo, a true pioneer in the fields of psychiatry, neurology, and neurodegenerative research. From his early work to his current role at BioVie, Dr. Palum…
Welcome to this blog post, a companion piece to our recent podcast episode featuring Nicholas Kadysh, CEO of PharmAla Biotech. In this episode, which you can listen to here, we delved into PharmAla Biotech's groundbreaking work in revolutionizing GM…
CEO, bioaccess®
Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America, Eastern Europe (the Balkans), and Australia as global leaders in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.
Business Development Director, bioaccess®
Jesus E. Moreno is a business development director who provides efficient and reliable clinical research services in Latin America. With a passion for driving innovation in the healthcare sector, Jesus leverages his bilingual biomedical engineering background and his understanding of the unique challenges that Medtech startups face to provide valuable support and deliver accelerated clinical study results. Jesus profoundly understands the critical role that reliable and streamlined clinical research plays in the success of Medtech startups. He firmly believes that by offering cost-effective solutions without compromising quality, Medtech startups can achieve their clinical goals faster and make a meaningful impact in the healthcare industry. Jesus is passionate about supporting Medtech startups in their journey towards bringing innovative medical technologies to market. Jesus possesses the technical expertise to understand the complexities of medical devices and technologies. This knowledge enables him to identify tailored solutions that meet the specific needs of Medtech startups. Jesus has a bachelor's degree in biomedical engineering and a master's degree in electronics engineering.